Medical > Boehringer Ingelheim – Aggrenox
SimpleViewer requires JavaScript and the Flash Player. Get Flash.
Boehringer Ingelheim – Aggrenox
Aggrenox (aspirin/extended-release dipyridamole) is an important advance for patients who have already suffered an ischaemic stroke. The large ESPS-2 study identified that Aggrenox was twice as effective in preventing recurrent strokes as aspirin. The clips of the following 3D animations illustrate the mode of action of this medication.